Application of Support Vector Machine on fMRI Data as Biomarkers in Schizophrenia Diagnosis: A Systematic Review.
biomarkers
machine learning
resting-state fMRI
schizophrenia
support vector machine (SVM)
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2020
2020
Historique:
received:
31
01
2020
accepted:
08
06
2020
entrez:
17
7
2020
pubmed:
17
7
2020
medline:
17
7
2020
Statut:
epublish
Résumé
Non-invasive measurements of brain function and structure as neuroimaging in patients with mental illnesses are useful and powerful tools for studying discriminatory biomarkers. To date, functional MRI (fMRI), structural MRI (sMRI) represent the most used techniques to provide multiple perspectives on brain function, structure, and their connectivity. Recently, there has been rising attention in using machine-learning (ML) techniques, pattern recognition methods, applied to neuroimaging data to characterize disease-related alterations in brain structure and function and to identify phenotypes, for example, for translation into clinical and early diagnosis. Our aim was to provide a systematic review according to the PRISMA statement of Support Vector Machine (SVM) techniques in making diagnostic discrimination between SCZ patients from healthy controls using neuroimaging data from functional MRI as input. We included studies using SVM as ML techniques with patients diagnosed with Schizophrenia. From an initial sample of 660 papers, at the end of the screening process, 22 articles were selected, and included in our review. This technique can be a valid, inexpensive, and non-invasive support to recognize and detect patients at an early stage, compared to any currently available assessment or clinical diagnostic methods in order to save crucial time. The higher accuracy of SVM models and the new integrated methods of ML techniques could play a decisive role to detect patients with SCZ or other major psychiatric disorders in the early stages of the disease or to potentially determine their neuroimaging risk factors in the near future.
Identifiants
pubmed: 32670113
doi: 10.3389/fpsyt.2020.00588
pmc: PMC7326270
doi:
Types de publication
Systematic Review
Langues
eng
Pagination
588Informations de copyright
Copyright © 2020 Steardo, Carbone, de Filippis, Pisanu, Segura-Garcia, Squassina, De Fazio and Steardo.
Références
Circulation. 2015 Nov 17;132(20):1920-30
pubmed: 26572668
Schizophr Res. 2018 Feb;192:408-415
pubmed: 28476336
Conf Proc IEEE Eng Med Biol Soc. 2014;2014:6691-4
pubmed: 25571531
PLoS One. 2015 Mar 23;10(3):e0119089
pubmed: 25799236
Neurosci Lett. 2019 Jul 13;705:87-93
pubmed: 31022433
Neuropsychiatr Dis Treat. 2019 Jun 19;15:1605-1627
pubmed: 31354276
PLoS One. 2009;4(4):e5226
pubmed: 19381298
Schizophr Res. 2020 Jan;215:430-438
pubmed: 31439419
Psychiatr Danub. 2019 Sep;31(Suppl 3):261-264
pubmed: 31488738
Lancet. 2016 Jul 2;388(10039):86-97
pubmed: 26777917
Psychiatry Res Neuroimaging. 2019 Feb 28;284:1-8
pubmed: 30605823
Front Neuroinform. 2017 Sep 08;11:59
pubmed: 28943848
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
Int J Neuropsychopharmacol. 2018 Jan 1;21(1):33-41
pubmed: 29228204
J Digit Imaging. 2018 Apr;31(2):252-261
pubmed: 28924878
Psychiatry Res Neuroimaging. 2017 Jun 30;264:60-67
pubmed: 28463748
Schizophr Res. 2018 Feb;192:179-184
pubmed: 28587813
Hum Brain Mapp. 2017 Dec;38(12):5845-5858
pubmed: 28876500
Epidemiol Rev. 2008;30:67-76
pubmed: 18480098
Neuropsychopharmacology. 2015 Jun;40(7):1742-51
pubmed: 25601228
Brain Imaging Behav. 2019 Oct;13(5):1386-1396
pubmed: 30159765
Neuroimage Clin. 2019;22:101725
pubmed: 30798168
Control Clin Trials. 1996 Feb;17(1):1-12
pubmed: 8721797
Neuroimage Clin. 2017 Dec 05;17:704-716
pubmed: 29264112
BMC Psychiatry. 2015 Aug 12;15:193
pubmed: 26263900
Eur Neuropsychopharmacol. 2019 Apr;29(4):519-528
pubmed: 30770234
Hum Brain Mapp. 2019 Sep;40(13):3930-3939
pubmed: 31148311
Comput Math Methods Med. 2013;2013:867924
pubmed: 24489603
Schizophr Bull. 2017 May 1;43(3):473-475
pubmed: 28338845
Front Hum Neurosci. 2010 Oct 25;4:192
pubmed: 21119772
Alzheimers Dement (Amst). 2018 Aug 11;10:519-535
pubmed: 30364671
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:445-451
pubmed: 28823850
Front Hum Neurosci. 2013 Oct 22;7:702
pubmed: 24155713
Neurosci Biobehav Rev. 2012 Apr;36(4):1140-52
pubmed: 22305994
IEEE Trans Neural Netw. 1999;10(5):988-99
pubmed: 18252602
Neuroimage Clin. 2017 Feb 06;14:334-343
pubmed: 28229040
Sci Rep. 2017 Jul 14;7(1):5483
pubmed: 28710394
Cereb Cortex. 2007 Oct;17(10):2407-19
pubmed: 17204824
Schizophr Res. 2018 Feb;192:167-171
pubmed: 28601499
Neuroimage. 2014 Aug 1;96:183-202
pubmed: 24704268
Schizophr Res. 2020 Mar;217:13-16
pubmed: 31324441
Neural Netw. 2015 Aug;68:23-33
pubmed: 25965771
Neurosci Biobehav Rev. 2015 Oct;57:328-49
pubmed: 26254595